Contact

All Stories

  1. Bifidobacterium and the gut–immune axis: Mechanistic insights and therapeutic potential

    Article • Microbiological Research, December 2026, Elsevier

    Dr. Rupendra SHRESTHA

  2. Optimized polyethylene glycol precipitation yields high-purity, biologically active mouse liver tissue exosomes

    Article • Molecular Biology Reports, August 2026, Springer Science + Business Media

    Rajasekaran Subbarayan , Dr. Rupendra SHRESTHA

  3. Suppression of Dengue through Deployment of Male Wolbachia-Infected Mosquitoes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2026, New England Journal of Medicine (NEJM/MMS)

    Dr. Rupendra SHRESTHA

  4. Y/15 Chromosomal Translocation in Turner Syndrome: A Case of Unexplained Short Stature

    Article • Biomedical Research and Therapy, July 2026, Biomedical Research and Therapy

    Dr. Rupendra SHRESTHA

  5. Matrix-Based Hydrogels in Biomedical Applications: Design, Functionality, and Translational Insights

    Article • Biomedical Research and Therapy, February 2026, Biomedical Research and Therapy

    Dr. Rupendra SHRESTHA

  6. Emerging Trends and Applications of Green Nanotechnology in Healthcare

    Article • February 2026, Taylor & Francis

    Dr. Rupendra SHRESTHA

  7. Exploring Fecal Microbiota Transplantation: Potential Benefits, Associated Risks, and Challenges in Cancer Treatment

    Article • Cancer Reports, January 2026, Wiley

    Rajasekaran Subbarayan , Dr. Rupendra SHRESTHA

  8. Biocompatible PEGylated Carbon Quantum Dots Synthesized From Citrus Peel: Evaluation of Cell‐Tracer Activity and In Vivo Imaging Potential

    Article • Journal of Nanotechnology, January 2026, Wiley

    Rajasekaran Subbarayan , Dr. Rupendra SHRESTHA, Dr PREMKUMAR B

  9. Infectious Triggers and Immune Dynamics in Guillain–Barré Syndrome: Revisiting Campylobacter jejuni and the Silent Role of Haemophilus influenzae

    Article • MicrobiologyOpen, November 2025, Wiley

    Rajasekaran Subbarayan , Dr. Rupendra SHRESTHA

  10. Integration of Artificial Intelligence and Biomaterials

    Article • November 2025, Taylor & Francis

    Dr. Rupendra SHRESTHA

  11. Nanotechnology and Biomaterials in Smart Manufacturing

    Article • November 2025, Taylor & Francis

    Dr. Rupendra SHRESTHA

  12. Liposome‐Encapsulated Melatonin Mitigates Amoxicillin‐Induced Neurotoxicity in a Zebrafish

    Article • Journal of Cellular and Molecular Medicine, November 2025, Wiley

    Dr. Rupendra SHRESTHA

  13. Gut microbiota-mediated oncogenesis in hepatocellular carcinoma: a new avenue for therapeutic intervention

    Article • International Journal of Surgery, October 2025, Wolters Kluwer Health

    Dr. Rupendra SHRESTHA

  14. Epithelial–Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical Implications

    Article • MedComm, August 2025, Wiley

    Dr. Rupendra SHRESTHA

  15. Intersection of COVID-19 and Alzheimer’s Disease: Genetic Insights and Neuropathological Consequences

    Article • Biochemical Genetics, July 2025, Springer Science + Business Media

    Rajasekaran Subbarayan , Dr. Rupendra SHRESTHA

  16. Circulating miR‐542‐3p as a Prognostic Marker for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis

    Article • Journal of Cellular and Molecular Medicine, July 2025, Wiley

    Rajasekaran Subbarayan , Dr. Rupendra SHRESTHA

  17. Enhancing Colorectal Cancer Treatment: The Role of Bifidobacterium in Modulating Gut Immunity and Mitigating Capecitabine‐Induced Toxicity

    Article • Molecular Nutrition & Food Research, March 2025, Wiley

    Rajasekaran Subbarayan , Dr. Rupendra SHRESTHA

  18. Radiation therapy-induced normal tissue damage: involvement of EMT pathways and role of FLASH-RT in reducing toxicities

    Article • Radiation and Environmental Biophysics, January 2025, Springer Science + Business Media

    Dr. Rupendra SHRESTHA

  19. The Impact of SARS-CoV-2 on Liver Diseases and Potential Phytochemical Treatments

    Article • Infectious Microbes & Diseases, October 2024, Wolters Kluwer Health

    Dr. Rupendra SHRESTHA

  20. Six3 and Six6 jointly control diverse target genes in multiple cell populations over developmental trajectories of mouse embryonic retinal progenitor cells

    Article • PLOS One, October 2024, PLOS

    Dr. Rupendra SHRESTHA

  21. Construction of pVAX-1-based linear covalently closed vector with improved transgene expression

    Article • Molecular Biology Reports, August 2024, Springer Science + Business Media

    Dr. Rupendra SHRESTHA, Rajasekaran Subbarayan

  22. Molecular insights on Eltrombopag: potential mitogen stimulants, angiogenesis, and therapeutic radioprotectant through TPO-R activation

    Article • Platelets, June 2024, Taylor & Francis

    Dr. Rupendra SHRESTHA, Rajasekaran Subbarayan

  23. Conditioned medium-enriched umbilical cord mesenchymal stem cells: a potential therapeutic strategy for spinal cord injury, unveiling transcriptomic and secretomic insights

    Article • Molecular Biology Reports, April 2024, Springer Science + Business Media

    Dr. Rupendra SHRESTHA, Rajasekaran Subbarayan

  24. Exploring platelet-derived microvesicles in vascular regeneration: unraveling the intricate mechanisms and molecular mediators

    Article • Molecular Biology Reports, March 2024, Springer Science + Business Media

    Dr. Rupendra SHRESTHA, Rajasekaran Subbarayan

  25. Therapeutic potential of sulforaphane: modulation of NRF2-mediated PI3/AKT/mTOR pathway in oral fibrosis

    Article • Brazilian Dental Science, January 2024, Editora Cubo Multimidia

    Dr. Rupendra SHRESTHA

  26. Self-formation of concentric zones of telencephalic and ocular tissues and directional retinal ganglion cell axons

    Article • eLife, September 2023, eLife

    Dr. Rupendra SHRESTHA

  27. Self-formation of concentric zones of telencephalic and ocular tissues and directional retinal ganglion cell axons

    Article • June 2023, eLife

    Dr. Rupendra SHRESTHA

  28. Six3 and Six6 jointly regulate the identities and developmental trajectories of multipotent retinal progenitor cells in the mouse retina

    Article • May 2023, Cold Spring Harbor Laboratory Press

    Dr. Rupendra SHRESTHA

  29. Self-formation of concentric zones of telencephalic and ocular tissues and directional retinal ganglion cell axons

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Dr. Rupendra SHRESTHA

  30. Primary Immune Response Provides Protective Efficacy against SARS-CoV-2 Reinfection

    Article • Journal of Nepal Medical Association, August 2021, Journal of Nepal Medical Association (JNMA)

    Dr. Rupendra SHRESTHA, Mr Ram Bahadur Khadka

  31. Induced pluripotent stem cells are Japanese brand sources for therapeutic cells to pretrial clinical research

    Article • Progress in Stem Cell, June 2020, Biomedical Research and Therapy

    Dr. Rupendra SHRESTHA

  32. Effective differentiation and biological characterization of retinal pigment epithelium derived from human induced pluripotent stem cells

    Article • Current Eye Research, January 2020, Taylor & Francis

    Dr. Rupendra SHRESTHA

  33. Generation of hiPSC line TCIERi001-A from normal human epidermal keratinocytes

    Article • Stem Cell Research, October 2019, Elsevier

    Dr. Rupendra SHRESTHA

  34. Late Response of Antiretroviral Therapy in an HIV-1-Infected Patient due to Hepatitis B and C Coinfections: The First Case Report in Nepal

    Article • Case Reports in Medicine, February 2019, Hindawi Publishing Corporation

    Anup Bastola, Dr. Rupendra SHRESTHA, Sundar Khadka

  35. Aberrant hiPSCs-Derived from Human Keratinocytes Differentiates into 3D Retinal Organoids that Acquire Mature Photoreceptors

    Article • Cells, January 2019, MDPI AG

    Dr. Rupendra SHRESTHA, Dr DAH-CHING DING

  36. Induced pluripotent stem cells and derivative photoreceptor precursors as therapeutic cells for retinal degenerations

    Article • Tzu Chi Medical Journal, January 2019, Medknow

    Dr. Rupendra SHRESTHA

  37. Detection of Latent HIV-1 Infection and Drug Resistant Mutation Testing in Nepal: HIV-1 env V3 DNA Sequence and RT Gene (M184V) Mutation

    Article • Nepal Journal of Biotechnology, December 2016, Nepal Journals Online (NepJOL)

    Dr. Rupendra SHRESTHA

  38. Electrospun cellulose acetate phthalate nanofibrous scaffolds fabricated using novel solvent combinations biocompatible for primary chondrocytes and neurons

    Article • Tissue and Cell, December 2016, Elsevier

    Dr. Rupendra SHRESTHA

  39. Variation in growth pattern and morphological appearance of primary monolayer cultures of chondrocytes and neural cells isolated from the chick embryo at different stages

    Article • Acta Medica International, January 2015, Medknow

    Dr. Rupendra SHRESTHA